O
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Oct 2012)
What this means for you
This application is over — abandoned 15 Oct 2012. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85400188
- Mark type
- Design + words
- Filed
- 17 Aug 2011
- Published for opposition
- 17 Jan 2012
- Abandoned
- 15 Oct 2012
- Attorney of record
- John Christopher
Goods and services
- Class 001 — Chemicals: Chemical preparations, namely, buffers, polypeptides, nucleic acids for scientific research purposes, water-oil solutions, chemical preparations in the form of powders, chemical preparations in the form of ointments, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, and chemical additives, all for scientific research purposes; chemical agents, namely, polypeptides, nucleic acids for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Flourescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes
- Class 005 — Pharmaceuticals: Medicaments, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases, preparations for clinical diagnosis and analysis of animal and human diseases for clinical medical use; eukaryotic cells, eukaryotic cell culture lines, animal and human material in the nature of cells out of cell culture, and of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Fluorescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissues, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for medical purposes, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; sanitary preparations for medical purposes, namely, pharmaceutical agents for dental care
Owner
- MICROMET AG, 81477 Munchen, DE
- MICROMET AG, 81477 Munchen, DE
Prosecution history
- 15 Oct 2012 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 15 Oct 2012 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Mar 2012 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jan 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jan 2012 — PUBLISHED FOR OPPOSITION
- 28 Dec 2011 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Dec 2011 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 08 Dec 2011 — POST PUBLICATION AMENDMENT - ENTERED
- 08 Dec 2011 — ASSIGNED TO LIE
- 07 Dec 2011 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Dec 2011 — ASSIGNED TO EXAMINER
- 23 Aug 2011 — NOTICE OF DESIGN SEARCH CODE MAILED
- 22 Aug 2011 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Aug 2011 — NEW APPLICATION ENTERED